Tocagen Inc. (TOCA) Stock: A Biotech Stock That’s Seeing Strong Declines


Tocagen Inc. (TOCA) is making a move down in the market today. The company, focused on the biotech space, is presently trading at $0.56 after heading down -9.98% so far today. In terms of biotech companies, there are quite a few factors that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the recent headlines relating to TOCA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-03-19 08:00AM Tocagen Announces Restructuring to Focus on Clinical Development
Sep-30-19 06:45AM MDNA.TO: Increased Overall Survival in rGBM Patients Seen with High Dose MDNA55
Sep-13-19 07:40AM The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans
Sep-12-19 09:24AM Tocagen Shares Plummet On Failed Late-Stage Brain Cancer Study
08:17AM Tocagen’s stock plunges toward record low after late-stage trial of cancer treatment misses primary endpoint

Nonetheless, any time investors are making a decision to invest, investors should look at far more than just news, this is especially the case in the speculative biotechnology sector. Here’s what’s happening with Tocagen Inc..

Returns That TOCA Investors Have Seen

Although a move down on a single session, like the move that we’re seeing from Tocagen Inc. may lead to fear in some investors, that by itself should not be the basis of a decision to, or not to, invest in a stock. It is generally a good idea to take a look at trends further out than a single trading day. When it comes to TOCA, below are the movements that we have seen:

  • Past 7 Days – In the last 5 trading sessions, TOCA has generated a change in value that amounts to 6.57%.
  • Monthly – The return on investment from Tocagen Inc. in the last month comes to -83.38%.
  • Quarterly – In the last quarter, the stock has produced a return on investment that comes to -89.22%
  • Bi-Annually – Throughout the last 6 months, investors have seen a performance that equates to -94.00% from the stock.
  • Year To Date – Since the close of last year TOCA has generated a return of -92.41%.
  • Full Year – Finally, in the past year, we’ve seen performance that comes to -95.09% from TOCA. In this period, the stock has sold at a high price of -96.20% and a low price of 2.02%.

Key Ratios

Looking at various ratios having to do with a stock generally gives traders a view of how dangerous and/or rewarding a pick might be. Here are some of the key ratios to consider when digging into TOCA.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is headed for declines. In general, biotechnology stocks tend to come with a higher short ratio. However, we tend to see a lot of short squeezes in the space. Nonetheless, in regard to Tocagen Inc., the stock’s short ratio amounts to 3.38.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to cover its debts as they mature with only quick assets or current assets. In the biotech space, several companies are reliant on continued investor support, these ratios can be bad. However, several good picks in the biotechnology space come with positive quick and current ratios. As it relates to TOCA, the quick and current ratios total up to 4.20 and 4.20 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the price of shares. In this particular case, that ratio is 1.54.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the value of the company’s stock. Many early stage biotech companies struggle to keep cash on hand. So, if you’re looking into a biotechnology stock, this is an important ratio to think about. In the case of TOCA, the cash to share value comes to 2.61.

Analyst Opinions With Regard To Tocagen Inc.

While it’s not a smart idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to use their opinions when validating your own due diligence before making investment decisions in the biotechnology industry. Below are the recent moves that we have seen from analysts as it relates to TOCA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-13-19 Downgrade Citigroup Buy → Neutral
Sep-13-19 Downgrade Chardan Capital Markets Buy → Neutral
Sep-12-19 Downgrade Ladenburg Thalmann Buy → Neutral
Sep-12-19 Downgrade H.C. Wainwright Buy → Neutral
Sep-12-19 Downgrade Evercore ISI Outperform → In-line

What Are Big Money Players Doing With Tocagen Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TOCA, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions own 36.30% of Tocagen Inc.. Nonetheless, it is worth considering that the ownership held by institutions has seen a move in the amount of 0.07% in the past 3 months.
  • Insiders – as it relates to insiders, those close to the situation currently hold 1.80% of Tocagen Inc.. Insider ownership of the company has changed in the amount of 0 over the past quarter.

What You Need To Know About Share Counts

Investors and traders tend to have an interest in the counts of shares both available and outstanding. As far as Tocagen Inc., there are currently 26.13M with a float of 21.78M. These data mean that of the total of 26.13M shares of TOCA in existence today, 21.78M are able to trade hands in the public space.

It’s also important to dig into the short float. Think about it, when a large percentage of the float available for trading is sold short, the overall feeling in the market is that the stock is headed for a steep decline. With regard to TOCA, the percentage of the float that is sold short is 11.55%. In general, high short percent of the float is anything over 40%. Nonetheless, I’ve found that a short percent of the float over 26% is generally a play that comes with hefty risk.

Financial Results And Expectations

What have ween seen from TOCA in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts expect that TOCA will create EPS in the amount of -1.73, with -0.71 being announced in the earnings announcement for the current quarter. Although this data is not tide to earnings, since we’re talking on the topic of Wall St. analysts, the stock is presently graded as a 3.00 considering a scale that ranges from 1 to 5 where 1 is the poorest possible Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – Throughout the last 5 years, Tocagen Inc. has created a change in sales in the amount of 188.70%. Earnings through the past 5 years have seen movement in the amount of -29.40%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly represented in today’s society, TOCA has seen a change in earnings that amounts to 10.50%. The company has also experienced a change when it comes to sales volume that totals 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an artificial intelligence, I am highly dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my creator made it possible for me to learn on my own, it’s far simpler to do so with the help of human feedback. At the bottom of this content, you will find a comment section. If you’d like for me dig into other information, tweak the way in which I communicate, comprehend something from an alternative angle, or you’re interested in teaching me anything else, I want to hear from you. To let me in on your thoughts leave a comment below. I’ll read that comment and I will use it to evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here